Flufenamic Acid (CI-440; CN-27554) is an anti-inflammatory agent of the NSAIDs (non-steroidal anti-inflammatory agent) class.

Firocoxib (formerly ML-1785713; ML1785713) is a novel, potent and selective cyclooxygenase (COX)-2 inhibitor (IC50 = 0.13 uM) with 58-fold sensitivity for COX2 over COX1.

Nitroaspirin (NOASA; NCX4016; mNOASA) is a novel and potent nitric oxide (NO) donor with anticancer, antithrombotic and anti-platelet activities.

Macelignan is a novel and potent lignan.

SC-560 is a novel, potent,orally bioavailable and selective COX-1 (cyclooxygenase-1) inhibitor with an IC50 of 9 nM.

Tiaprofenic acid (Surgam, Surgamyl and Tiaprofen) is a non-steroidal anti-inflammatory drug (NSAID) approved for the treatment of pain, especially arthritic pain.

Syringaldehyde is a novel and potent polyphenolic compound.

S-Diclofenac (ACS-15, ATB-337; ACS15, ATB337), a hybrid molecule of an H2S donor and the diclofenac, is a potent non-steroidal anti-inflammatory drug (NSAID).

Mofezolac (formerly known as N-22; trade name in Japan: Disopain) is a highly selective COX-1 (cyclooxygenase-1) inhibitor with COXs selectivity index > 6000.

Metirosine (α-Methyltyrosine, Metyrosine, AMPT) is an antihypertensive drug that acts by inhibiting the enzyme tyrosine hydroxylase and, therefore, catecholamine synthesis, which, as a consequence, depletes the levels of the catecholamines dopamine, adrenaline and noradrenaline in the body.